FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression

Marten Hornsveld(Utrecht University), Lydia M.M. Smits(Utrecht University), Maaike Meerlo(Utrecht University), Miranda van Amersfoort(Utrecht University), Marian J.A. Groot Koerkamp(Princess Máxima Center), Dik van Leenen(University Medical Center Utrecht), David E.A. Kloet(University Medical Center Utrecht), Frank C. P. Holstege(Princess Máxima Center), Patrick W.B. Derksen(Utrecht University), Boudewijn Burgering(Utrecht University), Tobias B. Dansen(University Medical Center Utrecht)
Cancer Research
February 13, 2018
Cited by 90

Abstract

Abstract FOXO transcription factors are regulators of cellular homeostasis and putative tumor suppressors, yet the role of FOXO in cancer progression remains to be determined. The data on FOXO function, particularly for epithelial cancers, are fragmentary and come from studies that focused on isolated aspects of cancer. To clarify the role of FOXO in epithelial cancer progression, we characterized the effects of inducible FOXO activation and loss in a mouse model of metastatic invasive lobular carcinoma. Strikingly, either activation or loss of FOXO function suppressed tumor growth and metastasis. We show that the multitude of cellular processes critically affected by FOXO function include proliferation, survival, redox homeostasis, and PI3K signaling, all of which must be carefully balanced for tumor cells to thrive. Significance: FOXO proteins are not solely tumor suppressors, but also support tumor growth and metastasis by regulating a multitude of cellular processes essential for tumorigenesis. Cancer Res; 78(9); 2356–69. ©2018 AACR.


Related Papers

No related papers found

Powered by citation graph analysis